journal article·2016-04-02

Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis

Sushant Chaudhary, Tarun Garg, Goutam Rath, Rs Rayasa Murthy, Amit K. Goyal

Publisher page

Abstract

The method based on integrating the principles of solid dispersion and nanocrystal techniques was developed to prepare polymer crystals (PCs) of mebendazole (MBZ) and polyethylene glycol (PEG). Powder X-Ray diffraction (PXRD) of the PC crystals shows the required integrated crystalline and amorphous regions. The in vitro solubility studies showed a 32-fold increase in the solubility of the drug. Tests of dissolution of the PCs showed that the crystals have an enhanced dissolution rate in comparison to those in the MF. The results of the pharmacokinetic study showed a 2.12-fold increase in the bioavailability of the drug. Thus, the present study has proved the potential in enhancing solubility, dissolution, and bioavailability of the drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

,

References (45)

Show source-provided references
1. 10.1016/S0065-308X(08)60151-710.1016/S0065-308X(08)60151-7 ↗
2. 10.3109/1061186X.2014.95066410.3109/1061186X.2014.950664 ↗
3. 10.1248/cpb.39.215810.1248/cpb.39.2158 ↗
4. 10.1016/j.ejps.2008.01.00710.1016/j.ejps.2008.01.007 ↗
5. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
6. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
7. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
8. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
9. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
10. Garg T, Rath G, Goyal AK. 2014c. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
11. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
12. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
13. 10.1007/978-3-662-45775-7_410.1007/978-3-662-45775-7_4 ↗
14. Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
15. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
16. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
17. 10.1166/jbt.2014.121410.1166/jbt.2014.1214 ↗
18. 10.3109/10717544.2014.92876010.3109/10717544.2014.928760 ↗
19. 10.3109/10717544.2014.93553110.3109/10717544.2014.935531 ↗
20. 10.3109/21691401.2014.98430310.3109/21691401.2014.984303 ↗
21. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
22. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
23. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
24. Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
25. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
26. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
27. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
28. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
29. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
30. Kaur V, Garg T, Rath G, Goyal AK. 2014i. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 1–12.
31. Malik R, Garg T, Goyal AK, Rath G. 2014. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. 1–16.
32. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
33. 10.3109/21691401.2014.92400710.3109/21691401.2014.924007 ↗
34. Morie A, Garg T, Goyal AK, Rath G. 2014. Nanofibers as novel drug carrier –An overview. Artif Cells Nanomed Biotechnol. 1–9.
35. 10.3109/21691401.2014.96619510.3109/21691401.2014.966195 ↗
36. 10.1021/bc700465v10.1021/bc700465v ↗
37. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
38. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
39. Safioleas M, Misiakos EP, Kakisis J, Manti C, Papachristodoulou A, Lambrou P, et al. 2000. Surgical treatment of human echinococcosis. Int Surg. 85:358–365.
40. Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S, Markandeywar T. 2014a. Nanogel-an advanced drug delivery tool: Current and future. Artif Cells Nanomed Biotechnol. 1–13.
41. Sharma R, Garg T, Goyal AK, Rath G. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
42. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
43. Singh B, Garg T, Goyal AK, Rath G. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
44. Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
45. 10.1016/j.ijpharm.2007.02.00510.1016/j.ijpharm.2007.02.005 ↗